Cefepime
1 g № 1, № 5, № 50
Group of action
Active ingredient
Dosage form
Powder for solution for injections
ATC code
J01DE01
RX/OTC
RX
Marketing authorisation no.
UA/13564/01/01
General properties
Pharmacotherapeutic group
Antimicrobials for systemic use. β-lactam antibiotics. fourth-generation cephalosporins.
Indications
Infections which pathogens susceptible to cefepime.
Adults:
- septicemia;
- intra-abdominal infections, including peritonitis and biliary tract infections;
- skin infections and subcutaneous tissue;
- gynecological infections;
- respiratory tract infections including pneumonia, bronchitis;
- prevention of postoperative complications in intra-abdominal surgery;
- an empirical therapy of patients with neutropenic fever.
Children.
- pneumonia;
- urinary tract infections including pyelonephritis;
- skin and subcutaneous tissue infections ;
- septicemia;
- an empirical therapy of patients with neutropenic fever;
- bacterial meningitis.
Contraindications
Increased sensitivity to antibiotics of cephalosporin group or L-arginine, penicillin and other β-lactam & nbsp; antibiotics.
Pharmaceutical characteristics
Basic physical and chemical properties
The powder of white to light yellow in color.
Shelf life
2 years.
Storage conditions
Keep out of reach of children in original packaging at temperature not exceeding 25 оС.
Manufacturer
PJSC "Lekhim-Kharkiv".
Location
36, Severyna Pototskoho St., 61115 Kharkiv, Ukraine.
